NCT02455310

Brief Summary

This study will perform a retrospective analysis to evaluate the effectiveness of a multicomponent educational intervention to improve medication use and management of behavioral and psychological symptoms of dementia, relative to a statewide intervention that has been ongoing. Medication use and symptom severity outcomes will be compared among intervention counties and demographically similar non-intervention counties.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44,524

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

April 30, 2015

Completed
27 days until next milestone

First Posted

Study publicly available on registry

May 27, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

May 14, 2019

Status Verified

May 1, 2019

Enrollment Period

6.4 years

First QC Date

April 30, 2015

Last Update Submit

May 10, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Antipsychotic use

    Antipsychotic use

    Up to 4 years

  • Anticholinergic Use

    Anticholinergic use

    Up to 4 years

Secondary Outcomes (11)

  • Olanzapine use in patients with metabolic disorders

    Up to 4 years

  • Excessive antipsychotic dose

    Up to 4 years

  • Benzodiazepine use

    Up to 2 years

  • Quetiapine or clozapine use only among antipsychotic users with Parkinson's disease or Lewy body dementia

    Up to 4 years

  • Antipsychotic use in people with dementia

    Up to 4 years

  • +6 more secondary outcomes

Study Arms (2)

Outpatients with dementia

Medication use will be evaluated among outpatients with dementia in intervention and control counties, as well as statewide to evaluate the long-term effectiveness of the statewide intervention.

Behavioral: Educational activities to improve dementia care

Nursing home residents

Medication use and behavioral outcomes will be evaluated among nursing home residents in intervention and control counties, as well as statewide to evaluate the long-term effectiveness of the statewide intervention.

Behavioral: Educational activities to improve dementia care

Interventions

The multicomponent intervention included active dissemination of educational resources and optional participation in specialist consultation sessions for up to 6 months. The standard intervention included education through a website or conferences, including clinical tools to support implementation of best practices.

Nursing home residentsOutpatients with dementia

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All Iowa Medicare beneficiaries who are nursing home residents or diagnosed with dementia and meet other eligibility criteria, for each year from 2011 to 2014.

You may qualify if:

  • Current Medicare fee-for-service plan and Part D enrollment for at least 3 months prior to the month of interest and during the month of interest (allowing a gap of one month to be considered as continuous enrollment if the person is enrolled during the month of interest)
  • Age greater than or equal to 66 years at the end of a year of interest
  • Any dementia diagnosis prior to the month of interest, or current resident of a nursing home
  • For the nursing home analysis, at least 14 days in the facility in the month being classified

You may not qualify if:

  • Greater than 15 days of the month of interest when prescription fills are unobservable from Medicare Part D claims due to hospital inpatient status, skilled nursing facility resident status, or hospice enrollment
  • A diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, Huntington's disease, Down's syndrome, or mental retardation or developmental disability at any time during the study period. Diagnoses after entry into the study sample will be included because of the limited look-back period to define some conditions for some individuals, and because these are generally not conditions with late-life onset so they are assumed to have been present prior to the first occurrence of a diagnosis in the available data
  • Currently comatose based on the most recent MDS assessment-if currently in a nursing home

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Iowa College of Public Health

Iowa City, Iowa, 52246, United States

Location

MeSH Terms

Conditions

Dementia

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Ryan Carnahan, PharmD, MS

    University of Iowa

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 30, 2015

First Posted

May 27, 2015

Study Start

January 1, 2011

Primary Completion

June 1, 2017

Study Completion

November 1, 2018

Last Updated

May 14, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Other than exposure data which is identifiable, the evaluation is based on CMS data which cannot be shared without a data reuse agreement.

Locations